You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

haematological malignancies

Showing 1 - 25 of 3,040
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Physical Activity in Older Haematological Malignancies: ACCES

Not yet recruiting
  • Geriatric
  • Haematologic Neoplasm
  • Physical activity (PA) program
  • Toulouse, France
    Chu de Toulouse
Oct 20, 2023

Hematological Malignancy Trial (Thymoglobulin Injectable Product)

Not yet recruiting
  • Hematological Malignancy
  • Thymoglobulin Injectable Product
  • (no location specified)
Sep 27, 2023

Hematological Malignancies Trial in Limoges ("Blend of ginger and lemon essential oils", "Neutral oil")

Not yet recruiting
  • Hematological Malignancies
  • "Blend of ginger and lemon essential oils", "Neutral oil"
  • Limoges, France
    University Hospital, Limoges
Nov 20, 2023

FID and QoL in Oncological and With Haematological Malignancies

Recruiting
  • Functional Iron Deficiency
    • Luzern, Switzerland
      Luzerner Kantonsspital
    Apr 16, 2022

    Haematological Malignancy, Hypogammaglobulinemia Trial (trimethoprim-sulfamethoxazole (co-trimoxazole), amoxycillin/clavulanic

    Not yet recruiting
    • Haematological Malignancy
    • Hypogammaglobulinemia
    • trimethoprim-sulfamethoxazole (co-trimoxazole)
    • +2 more
    • (no location specified)
    Jan 4, 2023

    tHe Early Recognition of Febrile Neutropenia in Haematological

    Recruiting
    • Haematological Malignancy
    • +4 more
    • TempTraq temperature monitor
    • Wellington, New Zealand
      Malaghan Institute of Medical Research
    Jan 10, 2022

    New Diagnostics in Neutropenia

    Not yet recruiting
    • Febrile Neutropenia
    • T2 magnetic resonance
    • Brisbane, Queensland, Australia
      Royal Brisbane Hospital
    Jun 7, 2022

    Haematological Malignancies Trial in Worldwide (AZD0466, Voriconazole)

    Recruiting
    • Haematological Malignancies
    • Scottsdale, Arizona
    • +34 more
    Dec 15, 2022

    Haematological Malignancy Trial in Parkville (Nivolumab Injection)

    Active, not recruiting
    • Haematological Malignancy
    • Nivolumab Injection
    • Parkville, Victoria, Australia
      Royal Melbourne Hospital
    Sep 21, 2021

    Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (CCS1477, Pomalidomide,

    Recruiting
    • Haematological Malignancy
    • +4 more
    • Phoenix, Arizona
    • +14 more
    Aug 22, 2022

    Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

    Completed
    • Haematological Malignancies
    • CD25/71 allodepleted donor T-cells
    • London, United Kingdom
    • +1 more
    Jul 18, 2022

    Hematological Malignancies Treated With Intensive Chemo Trial in Saint-Étienne (Tranexamic acid)

    Recruiting
    • Hematological Malignancies Treated With Intensive Chemotherapy
    • Tranexamic acid
    • Saint-Étienne, France
      CHU de Saint-Etienne
    Feb 7, 2022

    Relapsed or Refractory Haematological Malignancies Including, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in

    Completed
    • Relapsed or Refractory Haematological Malignancies Including
    • +10 more
    • Aachen, Germany
    • +11 more
    Oct 21, 2021

    Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple

    Recruiting
    • Multiple Myeloma
    • Wolverhampton, United Kingdom
      The Royal Wolverhampton NHS Trust
    Nov 9, 2021

    Adapted Physical Activity, Hematological Malignancies, Anxiety Trial (Classical APA group:, APA with Exergaming device, APA

    Not yet recruiting
    • Adapted Physical Activity
    • +3 more
    • Classical APA group:
    • +2 more
    • (no location specified)
    Jul 25, 2022

    Advanced Haematological Malignancies Trial in Worldwide (AZD4573, Acalabrutinib)

    Recruiting
    • Advanced Haematological Malignancies
    • Duarte, California
    • +38 more
    Jul 22, 2022

    Immunogenicity of Covid-19 Vaccination for Hematological

    Active, not recruiting
    • Immunogenicity
    • +3 more
      • Varese, Lombardia, Italy
        UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione M
      Sep 10, 2021

      Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical

      Active, not recruiting
      • Hodgkin's Lymphoma
      • +8 more
      • Reduced intensity haplodentical stem cell transplant
      • Myeloablative haploidentical stem cell transplant
      • Birmingham, United Kingdom
      • +11 more
      Sep 27, 2021

      Lateral Flow Immunoassays for Detection of SARS-CoV-2 Antibodies

      Recruiting
      • Solid Organ Transplant Recipients
      • +2 more
      • self-administered lateral flow assays
      • Bristol, United Kingdom
      • +3 more
      May 25, 2022

      Cancer, Malignancy, Refractory Cancer Trial in Singapore (Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted ?d T

      Not yet recruiting
      • Cancer
      • +3 more
      • Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells (CTM-N2D)
      • Singapore, Singapore
        National University Hospital
      Mar 20, 2022

      Breast Cancer, Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Worldwide (CB-103)

      Recruiting
      • Breast Cancer
      • +7 more
      • Santa Monica, California
      • +19 more
      Jan 6, 2022

      Acute Myeloid Leukemia, Myelodysplastic Syndrome, Diffuse Large B Cell Lymphoma Trial in France (Early palliative care

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Early palliative care integration
      • Chambéry, France
      • +5 more
      Mar 23, 2021

      Cognitive Impairment, Haematological Malignancy, Chemo-brain Trial in Milan (Cognitive Assessment, Cytokine dosage)

      Not yet recruiting
      • Cognitive Impairment
      • +2 more
      • Cognitive Assessment, Cytokine dosage
      • Milan, Italy
        ASST SANTI PAOLO CARLO - SAN CARLO BORROMEO HOSPITAL - SSd. Onco
      Dec 14, 2020

      Haematological Malignancy Trial in Nice (6 sessions of adapted physical activity after stem cell transplant)

      Recruiting
      • Haematological Malignancy
      • 6 sessions of adapted physical activity after stem cell transplant
      • Nice, France
        CHU NICE, hopital ARCHET 1, hématologie
      Jun 13, 2022

      Neuropathy and Cognitive Impairment Following Treatment for

      Recruiting
      • Chemotherapy-induced Peripheral Neuropathy
        • Aalborg, Denmark
          Department of Haematology, Aalborg University Hospital
        Aug 14, 2020